Evidence map›Paper›PMID 41498550›Full record

ArticleAntimicrobial agents and chemotherapy2026

Beyond

Melissa Sassman, Michele Karolak, Margeurite Dallaire, Claire E Schaffer, Carlos Gartner, Calvin Vary, Roberto R Rosato, Adriana E Rosato

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Melissa Sassman *Center for Molecular Medicine, MaineHealth Institute for Research, Scarborough, Maine, USA.
Michele Karolak *Center for Molecular Medicine, MaineHealth Institute for Research, Scarborough, Maine, USA.
Margeurite DallaireCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, Maine, USA.
Claire E SchafferCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, Maine, USA.
Carlos GartnerCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, Maine, USA.
Calvin VaryCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, Maine, USA.
Roberto R RosatoCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, Maine, USA.
Adriana E RosatoCenter for Molecular Medicine, MaineHealth Institute for Research, Scarborough, Maine, USA.ORCID 0000-0001-6115-6955

Funding

Newly Identified mechanisms of Ceftaroline Resistance in MRSA Clinical StrainsR56AI118756 · NIAID · METHODIST HOSPITAL RESEARCH INSTITUTE · PI ROSATO, ADRIANA E · 2016 to 2016
$684k
NIAID NIH HHS R56 AI118756
6 · The paper itself

Abstract

High-level resistance to ceftaroline, a fifth-generation β-lactam critical for treating methicillin-resistant

Indexed as

Anti-Bacterial AgentsBacterial ProteinsCephalosporinsMethicillin-Resistant Staphylococcus aureusPenicillin-Binding ProteinsCeftarolineGene Expression Regulation, BacterialHumansMicrobial Sensitivity TestsMutationThird Generation CephalosporinsAnti-Bacterial AgentsBacterial ProteinsCeftarolineCephalosporinsmecA protein, Staphylococcus aureusPenicillin-Binding ProteinsThird Generation Cephalosporinsceftarolinecell wall remodelingMRSAresistance mechanismsrpoB

Identifiers

PMID41498550
PMCPMC12888875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.